Cargando…

Dual Inhibition of DKC1 and MEK1/2 Synergistically Restrains the Growth of Colorectal Cancer Cells

Colorectal cancer, one of the most commonly diagnosed cancers worldwide, is often accompanied by uncontrolled proliferation of tumor cells. Dyskerin pseudouridine synthase 1 (DKC1), screened using the genome‐wide RNAi strategy, is a previously unidentified key regulator that promotes colorectal canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kan, Guangyan, Wang, Ziyang, Sheng, Chunjie, Chen, Gong, Yao, Chen, Mao, Yizhi, Chen, Shuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132060/ https://www.ncbi.nlm.nih.gov/pubmed/34026451 http://dx.doi.org/10.1002/advs.202004344

Ejemplares similares

Inhibition of DKC1 induces telomere-related senescence and apoptosis in lung adenocarcinoma
por: Kan, Guangyan, et al.
Publicado: (2021)

RNAi Screening Identifies that TEX10 Promotes the Proliferation of Colorectal Cancer Cells by Increasing NF‐κB Activation
por: Wang, Ziyang, et al.
Publicado: (2020)

DKC1 overexpression associated with prostate cancer progression
por: Sieron, P, et al.
Publicado: (2009)

DKC1 enhances angiogenesis by promoting HIF-1α transcription and facilitates metastasis in colorectal cancer
por: Hou, Pingfu, et al.
Publicado: (2019)

Dyskeratosis Congenita with DKC1 Mutation: A Case Report
por: Zhao, Xing-Yun, et al.
Publicado: (2020)

A missense variant in the nuclear localization signal of DKC1 causes Hoyeraal-Hreidarsson syndrome
por: Chu, Chia-Mei, et al.
Publicado: (2022)

The Food and Drug Administration-approved antipsychotic drug trifluoperazine, a calmodulin antagonist, inhibits viral replication through PERK-eIF2α axis
por: Mao, Yizhi, et al.
Publicado: (2022)

Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report
por: Ratnasamy, Vithiya, et al.
Publicado: (2018)

Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1
por: Carrascoso-Rubio, Carlos, et al.
Publicado: (2021)

The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer
por: Elsharawy, Khloud A., et al.
Publicado: (2020)

DKC1 is a transcriptional target of GATA1 and drives upregulation of telomerase activity in normal human erythroblasts
por: Richards, Laura A., et al.
Publicado: (2020)

A Novel Variant and a Missense Variant Identified in the DKC1 Gene in Three Chinese Familieswith Dyskeratosis Congenita
por: Yuan, Chunyu, et al.
Publicado: (2022)

CD8(+) T‐cell senescence and skewed lymphocyte subsets in young Dyskeratosis Congenita patients with PARN and DKC1 mutations
por: Zeng, Ting, et al.
Publicado: (2020)

UTP14A, DKC1, DDX10, PinX1, and ESF1 Modulate Cardiac Angiogenesis Leading to Obesity-Induced Cardiac Injury
por: Pan, Xiaoyu, et al.
Publicado: (2022)

DKC1 mutation causing different phenotypes in a family with X-linked Hoyeraal-Hreidarsson syndrome
por: Boufleur, Karine, et al.
Publicado: (2015)

Pseudogene fms-related tyrosine kinase 1 pseudogene 1 (FLT1P1) cooperates with RNA binding protein dyskeratosis congenita 1 (DKC1) to restrain trophoblast cell proliferation and angiogenesis by targeting fms-related tyrosine kinase 1 (FLT1) in preeclampsia
por: Chi, Zhenjing, et al.
Publicado: (2021)

Clinical heterogeneity in a family with DKC1 mutation, dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome in first cousins
por: Olivieri, Cristina, et al.
Publicado: (2017)

A novel cause of DKC1‐related bone marrow failure: Partial deletion of the 3′ untranslated region
por: Arthur, Jonathan W., et al.
Publicado: (2021)

SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1
por: Wu, Xiao, et al.
Publicado: (2023)

TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis
por: Shi, Hui, et al.
Publicado: (2021)

A multi-hit therapeutic nanoplatform for hepatocellular carcinoma: Dual stimuli-responsive drug release, dual-modal imaging, and in situ oxygen supply to enhance synergistic therapy
por: Chen, Taiying, et al.
Publicado: (2022)

Complete Genome Sequence of Mycobacterium tuberculosis DKC2, the Predominant Danish Outbreak Strain
por: Norman, Anders, et al.
Publicado: (2019)

LncRNA MEG3 inhibits non-small cell lung cancer via interaction with DKC1 protein
por: Yang, Zhi, et al.
Publicado: (2020)

NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells
por: Gao, Enyi, et al.
Publicado: (2023)

Dual FGFR and VEGFR inhibition synergistically restrain hexokinase 2-dependent lymphangiogenesis and immune escape in intrahepatic cholangiocarcinoma
por: Peng, Min, et al.
Publicado: (2023)

Complications for a Hoyeraal–Hreidarsson Syndrome Patient with a Germline DKC1 A353V Variant Undergoing Unrelated Peripheral Blood Stem Cell Transplantation
por: Chen, Rong-Long, et al.
Publicado: (2019)

Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway
por: Zeng, Zhou, et al.
Publicado: (2019)

miRNA326-5p Targets DKC1 Gene to Regulate Apoptosis-Related Proteins and Intervene in the Development of Neuroblastoma
por: Wang, Xiao-Hui, et al.
Publicado: (2023)

Theranostic Nanomedicine for Synergistic Chemodynamic Therapy and Chemotherapy of Orthotopic Glioma
por: Tan, Junyi, et al.
Publicado: (2020)

DKC1 Overexpression Induces a More Aggressive Cellular Behavior and Increases Intrinsic Ribosomal Activity in Immortalized Mammary Gland Cells
por: Guerrieri, Ania Naila, et al.
Publicado: (2020)

Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
por: Ewald, Florian, et al.
Publicado: (2015)

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6
por: Sorokin, Alexey V., et al.
Publicado: (2022)

PADI2‐Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1‐Mediated SOX2 mRNA Stability in Endometrial Cancer
por: Xue, Teng, et al.
Publicado: (2021)

Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI‐Visible Nanocarrier Targeting Hepatic Stellate Cells
por: Wu, Jun, et al.
Publicado: (2019)

The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
por: Kobelt, Dennis, et al.
Publicado: (2021)

Intron retention by a novel intronic mutation in DKC1 gene caused recurrent still birth and early death in a Chinese family
por: Guo, Qiufang, et al.
Publicado: (2022)

The synergistic effects of oxaliplatin and piperlongumine on colorectal cancer are mediated by oxidative stress
por: Chen, WeiQian, et al.
Publicado: (2019)

Mek1 and Mek2 Functional Redundancy in Erythropoiesis
por: Beuret, Laurent, et al.
Publicado: (2021)

LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway
por: Liu, Shi-Yuan, et al.
Publicado: (2021)

Dual Inhibition of MEK and PI3K Pathway in KRAS and BRAF Mutated Colorectal Cancers
por: Temraz, Sally, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2j2djb5cjrrog9ijmtupjv21lg